Haploidentical Lymphocytes With Nivolumab/Ara-C as Consolidation in Elderly AML Patients
Status:
Terminated
Trial end date:
2018-09-30
Target enrollment:
Participant gender:
Summary
A phase II trial to compare the efficacy and safety of nivolumab and intermediate dose
cytarabine with or without haploidentical lymphocyte infusion. To identify the role of
haploidentical lymphocytes in the treatment of acute myeloid leukemia in older adults. The
patients will be stratified based on the remission number (first or second)